AzTrials
AzTrials

StrokeNCT05060458

Increasing Insight in Spatial Neglect: Unraveling Its Longitudinal Interaction With Motor Function After Stroke

An observational study of Stroke and Spatial Neglect, run by Universiteit Antwerpen at 3 sites in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Goal: Various studies suggest a negative association between spatial neglect and motor outcomes after stroke (Barrett \& Muzaffar 2014) (Kwakkel 2014). Our goal is to assess: The longitudinal interaction of the recovery of spatial neglect with the recovery of motor function and outcomes (such as paresis, sitting… Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Stroke, Spatial Neglect, Postural Control
How many people
36 participants
Where
3 sitesBelgium
Study dates
1 Nov 2019to 11 Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: First-ever stroke patients (inpatient or outpatient)

Who may be able to join

  • First-ever, MRI- or CT-confirmed, ischemic or hemorrhagic, anterior circulation stroke
  • Age: 18 - 90 years
  • Moderate to severe weakness of the lower limb at baseline (MI </=75)
  • Pre-morbid independence in activities of daily living (mRS </=2) and gait (FAC >3)
  • Able to communicate and comprehend
  • Sufficient motivation to participate
  • Provided a written informed consent

Who cannot join

  • Other neurological condition affecting motor functions of the lower limbs
  • Pre-existing musculoskeletal impairment severely affecting the gait pattern
  • Medically unstable
  • Non-corrected vision disorders

Trial locations and contacts

3 sites in 1 country.

Belgium3 sites
  • Antwerp University Hospital

    Edegem

  • RevArte

    Edegem

  • GZA Ziekenhuis - campus St Augustinus & Campus St Vincentius

    Wilrijk

Other trials in Belgium

About this study

Goal: Various studies suggest a negative association between spatial neglect and motor outcomes after stroke (Barrett \& Muzaffar 2014) (Kwakkel 2014). Our goal is to assess:

  • The longitudinal interaction of the recovery of spatial neglect with the recovery of motor function and outcomes (such as paresis, sitting balance and standing balance)
  • Whether the association is different across the different subtypes of spatial neglect (visuospatial/personal/ADL-related)
  • The role of compensation strategies for balance control in patients with spatial neglect

To do so, we will perform a longitudinal cohort study in which we will repetitively assess post-stroke patients using a comprehensive assessment approach for both spatial neglect and motor outcomes. With regards to neglect, we will evaluate various aspects of both visuospatial and personal neglect. For motor outcomes, we will combine clinical and instrumented (biomechanical) assessment methods to evaluate post-stroke recovery of leg paresis, (sitting and standing) balance and gait.

Read the detailed description

Spatial neglect is a post-stroke disorder characterized by impaired awareness for stimuli located on the contralesional side of space. This neglect results in problems with reporting, responding or orienting toward contralesional stimuli, which cannot be explained by sensory or motor impairments. It can be present after a right- or left-sided brain lesion but is more frequently present in right-sided brain lesions. Within the first 2 weeks post-stroke, it occurs in approximately 50% of patients. Spontaneous neurological recovery of neglect follows a natural logistic pattern of improvement within the first 12 to 14 weeks post-stroke. Afterward, the curve flattens and the severity remains merely invariant, leaving 40% of patients with initial neglect still with symptoms at 1 year post-stroke.

The high frequency and persistence of spatial neglect might have major consequences; indeed, various studies suggest a negative association between spatial neglect and post-stroke recovery of motor function and abilities. Apart from the seemingly suppressive influence of VSN on the recovery of upper-limb strength and synergy acquisition, lower limb motor recovery, balance and functional mobility might also be affected. However, the longitudinal interactions between spatial neglect and lower limb motor recovery are complex and only partially understood, owing to a lack of prospective cohort studies evaluating this. Additionally, also the association between spatial neglect and balance and functional mobility is currently unclear. A comprehensive overview is lacking, even though both balance and functional mobility are likely to be affected in these patients. Indeed, spatial neglect is characterised by a spatial (orientational) bias of attention. This bias might reflect a disruption in spatial information processing, which is a neural process incorporating sensory information from multiple modalities, resolving sensory ambiguity and integrating afferent and efferent information. A bias in this information processing might impede postural control and therefore also balance and mobility. However, whether spatial neglect and these motor outcomes are longitudinally associated, and whether such association is similar for the different spatial neglect subtypes, is still unknown.

Our goal is to assess:

  • The longitudinal interaction of the recovery of spatial neglect with the recovery of motor function and outcomes (such as paresis, sitting balance and standing balance)
  • Whether the association is different across the different subtypes of spatial neglect (visuospatial/personal/ADL-related)
  • The role of compensation strategies for balance control in patients with spatial neglect

To do so, we will perform a longitudinal cohort study in which we will repetitively assess post-stroke patients using a comprehensive assessment approach for both spatial neglect and motor outcomes. With regards to neglect, we will evaluate various aspects of both visuospatial and personal neglect. For motor outcomes, we will combine clinical and instrumented (biomechanical) assessment methods to evaluate post-stroke recovery of leg paresis, (sitting and standing) balance and gait.

Recruitment: as early as possible after stroke on fixed time-points post-stroke as recommended by the Stroke Recovery and Rehabilitation Roundtable (internationally renowned field experts). We include patients at: ≤14 days, 3 weeks, or 5 weeks post-stroke. Inclusion in RevArte rehabilitation hospital, UZA, GZA St-Augustinus, GZA St-Vincentius and Reva Geel.

Outcome measures: include measures for spatial neglect, motor function and balance/mobility.

Data analysis: linear mixed models will be fitted to evaluate study results and therefore mean change over time.

Being tested
No intervention
Keywords
Stroke, Postural control, Spatial neglect
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • No interventionOther

    No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Rivermead Mobility Index

    Change in functional balance and mobility. Score from 0 to 15. Higher score means better performance.

    Measured: Change from <14 days to 3 weeks

  2. Change in Rivermead Mobility Index

    Change in functional balance and mobility. Score from 0 to 15. Higher score means better performance.

    Measured: Change from 3 weeks - 5 weeks

  3. Change in Rivermead Mobility Index

    Change in functional balance and mobility. Score from 0 to 15. Higher score means better performance.

    Measured: Change from 5 weeks - 8 weeks

  4. Change in Rivermead Mobility Index

    Change in functional balance and mobility. Score from 0 to 15. Higher score means better performance.

    Measured: Change from 8 weeks - 12 weeks

  5. Change in Broken Hearts Test

    Change in cancellation task for visuospatial neglect

    Measured: Change from <14 days to 3 weeks

  6. Change in Broken Hearts Test

    Change in cancellation task for visuospatial neglect

    Measured: Change from 3 weeks to 5 weeks

  7. Change in Broken Hearts Test

    Change in cancellation task for visuospatial neglect

    Measured: Change from 5 weeks to 8 weeks

  8. Change in Broken Hearts Test

    Change in cancellation task for visuospatial neglect

    Measured: Change from 8 weeks to 12 weeks

  9. Functional Ambulation Categories

    Walking evaluation. Score from 0-5. Higher score means better performance.

    Measured: Change from <14 days to 3 weeks

  10. Functional Ambulation Categories

    Walking evaluation. Score from 0-5. Higher score means better performance.

    Measured: Change from 3 weeks to 5 weeks

  11. Functional Ambulation Categories

    Walking evaluation. Score from 0-5. Higher score means better performance.

    Measured: Change from 5 weeks to 8 weeks

  12. Functional Ambulation Categories

    Walking evaluation. Score from 0-5. Higher score means better performance.

    Measured: Change from 8 weeks to 12 weeks

Secondary outcomes (10)
  1. Trunk Control Test - item quiet sitting for 30 seconds

    Sitting, hands on lap, feet of the ground. Score from 0 to 2. Higher score means better performance.

    Measured: <14 days, 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  2. Berg Balance Scale - item quiet standing for 2 minutes

    Ability to stand unsupported. Score from 0 to 4. Higher score means better performance.

    Measured: <14 days, 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  3. Motricity index - lower limbs

    Strength of the hip flexors, knee extensors and dorsiflexors (paretic vs non paretic limb)

    Measured: <14 days, 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  4. Fügl-Meyer Motor Assessment - lower limbs

    Selectivity of the paretic lower limb

    Measured: <14 days, 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  5. 5m walk test

    Walking speed

    Measured: <14 days, 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  6. Line Bisection Test

    Visuospatial neglect test

    Measured: 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  7. Visuospatial Search Time Test

    Visuospatial neglect test

    Measured: 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  8. Fluff Test

    Personal neglect test

    Measured: 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  9. Tactile extinction test

    Personal neglect test

    Measured: 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

  10. Catherine Bergego Scale

    ADL related neglect test

    Measured: 3 weeks, 5 weeks, 8 weeks, 12 weeks post-stroke

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2021
  2. Study start1 Nov 2019
  3. Primary completion11 Jul 2022
  4. Study completion11 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05060458
Sponsor's protocol ID
D0011000
Status last verified
Dec 2022
First submitted
8 Sep 2021
Last updated
23 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Embrechts E, Schroder J, Nijboer TCW, van der Waal C, Lafosse C, Truijen S, Saeys W. Does visuospatial neglect contribute to standing balance within the first 12 weeks post-stroke? A prospective longitudinal cohort study. BMC Neurol. 2024 Jan 22;24(1):37. doi: 10.1186/s12883-023-03475-1.

    PubMed 38254026

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Spatial Neglect, run by Universiteit Antwerpen at 3 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Rivermead Mobility Index (time frame: Change from <14 days to 3 weeks). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05060458, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in